The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress.  Winograd RP, Park B, Coffey B, Ghonasgi R, Blanchard B, Thater P, Brown KC.&nbs...

Breaking barriers: Assessing the feasibility and acceptability of telemedicine-assisted buprenorphine induction for opioid use disorder in India.  Ghosh A, Kale A, Laxmi R, Naik SS, Subodh BN, Basu D.  Indian J Psychiatry. 2024 Oct;66(...

Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study.  Anyanwu P, Olateju OA, Tata V, Varisco T, Gilbert LR, Ogunsanya ME, Essien EJ, Johnson ML, Thornton JD.  Harm Reduct J....

Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens.  McEvoy A, Rodrigues M, Dennis BB, Hudson J, Marsh DC, Worster A, Thabane L, Samaan Z.  Addict Behav Rep. 202...

Emergency department utilization of the methadone "72-hour rule" to bridge or initiate and link to outpatient treatment.  Huo S, Heil J, Salzman MS, Ely A, Snyder S, Terracciano D, Rafeq R, Ganetsky V, Carroll G, Haroz R.  Am J Emerg M...

Effectiveness of cognitive-behavioral therapy on mental health, life expectancy, and happiness in patients receiving methadone maintenance treatment.  Amiri P, Rasouli-Azad M, Afshari B, Chehri A, Amiri M, Rezaie Z.  J Educ Health Prom...